Endometriosis UK believes that women and those assigned female at birth in the UK should be able to choose the right ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug ...

A new combination pill, relugolix–estradiol–norethisterone, has been approved for treating endometriosis on the NHS. This marks the first long-term, daily oral treatment for the condition, offering a ...

But now the NHS England has approved a daily pill that could help manage pain and other symptoms for those living with the condition. The new tablet, known as relugolix combination therapy or Ryeqo, ...

The drug, called relugolix-estradiol-norethisterone (Ryeqo), works by blocking certain hormones and easing painful symptoms ...

The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels ...

The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...